Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension
Status:
RECRUITING
Trial end date:
2029-03-01
Target enrollment:
Participant gender:
Summary
Obesity is a global health concern that is associated with high blood pressure and an increased risk for developing cardiovascular disease. The purpose of this study is to find out if the investigational drug angiotensin-(1-7) can improve cardiovascular health in people with obesity and high blood pressure.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Acetates angiotensin I (1-7) Saline Solution Sodium Chloride